Professional Documents
Culture Documents
02 David SAP at Ranbaxy
02 David SAP at Ranbaxy
1 1
Agenda
About Ranbaxy IT at Ranbaxy The Good, The Bad and The Ugly
R/3 APO
Q&A
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
About Ranbaxy
Over 12,000 Workforce
Princeton NJ, North America
London, Europe
Business Model
Global Reach
Developed Markets
North America, EU, Japan
Product Portfolio
Generics Branded Generics Branded & OTC
Emerging markets
India, Romania, CIS, Africa
Manufacturing
Dosage Form API* - Vertical Integration In-house / Outsource The India advantage
We Deliver Value Everyday Global IT * NDDS - Novel Drug Delivery System, API Active Pharmaceutical Ingredients, FTF First to File
Global Presence
Global IT
Privileged and Confidential
Romania
USA
China
Ireland Malaysia
India
Nigeria
Global IT
Privileged and Confidential
Vietnam
7
Own Plants (Mohali, Poanta Sahib, Toansa, Dewas) API RM / Advanced Intermediate suppliers
Direct- todistributor API Contract Manufacturers Global Plants (Dewas, Paonta Sahib,Goa, Jejuri)
PM Suppliers
Global IT
Privileged and Confidential
API customers
8
API suppliers
Other RM suppliers
Backward Integrated (21 DF & API plants) 40+ API Contract Contract Manufacturers Manufacturers 30+ Third Party Suppliers ~ 1000+ Raw Materials 15000+ Packaging Materials
Customers in 125 countries 6 Distribution models ~7000 SKUs 3 new product introductions RW C&FA (India) per day
(India)
Stockists
PM Suppliers
Global IT
Privileged and Confidential
API customers
9
Global IT
Privileged and Confidential
We Deliver Value
R&D EverydayIII
R&D IV
10
2000
1607
~ 1900 e
1600
1339 1178
1200
800
400
Global IT
Privileged and Confidential
2005
2008
e - estimate 11
Copyright 2008 Ranbaxy Laboratories Limited * 3 year CAGR on like-to-like basis .i.e. excluding allied businesses divested in 2005
Terapia (Romania) Be-Tabs (South Africa) Allen (Italy) Ethimed (Belgium) Mundogen (Spain)
Derma Brands (BMS)
Zenotech (India) Krebs (India) Jupiter Biosciences(Ind.) Cardinal Drugs (India) Orchid Pharma (India) Auto-injector Tech.(USA)
Global IT
Privileged and Confidential
IT Top Priorities
People Retention, Development and Recruitment Accelerate Product to Market Time Enable Supply Chain Excellence Deliver Business Intelligence
Global IT
Privileged and Confidential
IT Overview at Ranbaxy
Mix of enterprise applications like SAP R/3, APO, BW, Pharma-co-vigilance, Document Management, Sales Force Automation and host of local applications including
workflows based applications and a strong web presence A highly scalable and fault-tolerant Infrastructure across the globe MS Exchange as global communication platform Major thrust on Information Security Business Continuity Plans for key systems Disaster Recovery setup for SAP R/3 environment.
Global IT
Privileged and Confidential
Swede n UK Canada Ireland Germany France Poland Ukraine Belgium Portugal Spain US Mexico Senegal Guatemala Ivory Coast Nigeria Cameroon Morocco
Russi Lithuani a Latvia a Belarus Austria Romania Italy Hungar y Egypt UAE Sri Ugand Lanka a Kenya Malaysia Mauritiu s Zimbabw e South Africa Kazakhsta n China Nepal Myanm India ar Vietnam Thailand
Japan
Bulgaria
Cambodi a Singapor e
Peru
Brazil Namibia
Ranbaxy Locations - 49 Overseas Locations with Exchange Server - 10 Locations With RPC \ Http from Corporate - 12 SAP R3 Locations - 19
Australia
Global IT
11-Jun-08
Global Data Centers having > 425 Servers across enterprise with averaged uptime 99.5% Keeping the Business Connected
Global IT
Privileged and Confidential
Some Certifications
Focus on IT Security & Processes First major Pharma organization in India to get certification
Global IT
Privileged and Confidential
Some Certifications
SAP CCC
Focus on SAP Support Processes and Documentation First company in Asia pacific to get certified by SOCA route First company in India to get recertified 3rd time
Global IT
Privileged and Confidential
~ 75% of global turnover and more than 100 sites worldwide run SAP We Deliver Value Everyday Global IT One System - Global Single Instance
Copyright 2008 Ranbaxy Laboratories Limited
19
Logistics Partners Germany (caremaxx), UK (CPD Logistics) France (CSP - batch process)
Subcontractors & Loan Licensees India(4) 59 LLs and 25 Subcontractors through Back Office
BW 7.0 CRM 4.0 XI 3.0 EP 7.0 SEM 6.0 HR 4.6c Solution Manager 4.0
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
SAP Resourcing
One global team (CoE) under single head with people in India, US and EU (primarily India) Day-to-Day Support is offshored in India All Implementations done with internal team APO Internal Team with partner for support New Age Products Internal Team with spot expertise External expertise is used to augment internal team only when required
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Global IT
Overall SAP has led to increase in sales, reduction in inventory, increase in productivity etc.
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Complete R/3 Roll-outs to top markets Clean-up Master Data Application consolidation of minor systems Plan HR ESS Deployment
Global IT
Privileged and Confidential
Commencement of APO
Key driver for implementing an APO at Ranbaxy was the increasing complexity of the Supply Chain due to rapid business growth.
FG SKUs: >7000 Active RM+PM SKUs: >20000 Active Countries: >100 Manufacturing plants: 16 own DF plants, 5 own API plants and > 40 Contract Manufacturers and Loan Licensees 4 New Products introduced everyday
Global IT
Privileged and Confidential
Immediate Objectives
Transform the supply chain to substantially improve customer service levels in the short term whilst maintaining optimal inventory levels
APO Implementation Provide integrated planning capability Improve analytical capabilities such as What-If analysis Provide automation of planning tasks Sustain/enhance Spectrum benefits
Spectrum
Provide End to end Supply Chain Visibility Increase flexibility and responsiveness of supply chain Support Ranbaxys vision and growth plan
Global IT
Privileged and Confidential
SAP-SCM(APO)
Demand Planning Supply Network Planning Production Planning/ Detailed Sch. Scheduling Available To Promise Transportation Planning
BW
Integration Layer
Transaction System
Source: SAP
Global IT
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
DF Schedule NDR - API Mfg. Commits Commit Vs. Actual SC/MFG NDR Global NDR-Plant Requirement Vs. Commit SC
Process
Demand Forecast
FG Inventory Turns SC
DIFOT Markets
Global IT
Privileged and Confidential
SAP Support SAP Executive support Subj. Matter Expertise Change Ranbaxy end user & usage of Management system Adoption across enterprise and continuous improvement Implementati Focus within business functions on Scope & Vertical Integration Focus Future Capabilities Order Promising Supplier Relationship Management
Global IT
Privileged and Confidential
Critical Issues
Ranbaxy Senior Executive Ownership SAP Support and APO Capability Change Management and Project Team Burnout
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
Increase in Throughput: Number of SKUs delivered by Block B used to average between 250-275. Since May, this has gone up to 280-300 with a maximum of 306 in May 2007. Reduction in PM Inventory: There has been a reduction in PM inventory in Dewas to the tune of Rs. 2.4 Cr over May-July 2007. This can primarily be attributed to APO based planning. Dewas is still in stabilization stage. Results shall improve further. Global IT
We Deliver Value Everyday
Copyright 2008 Ranbaxy Laboratories Limited 46
Sponsorship
COO engaged actively to spearhead project
Change Management
Project Management changed Once there were demonstrable results, people wanted to be associated with success Moved key project team members into operations
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
As in the movie.
Work with the Ugly Overcome the Bad Keep focused on the gold And you will be the Good
We Deliver Value Everyday
Copyright 2008 Ranbaxy Laboratories Limited 50
Global IT
Privileged and Confidential
Global IT
Privileged and Confidential
51 51
Global IT
Privileged and Confidential
52 52
Weitergabe und Vervielfltigung dieser Publikation oder von Teilen daraus sind, zu welchem Zweck und in welcher Form auch immer, ohne die ausdrckliche schriftliche Genehmigung durch SAP AG nicht gestattet. In dieser Publikation enthaltene Informationen knnen ohne vorherige Ankndigung gendert werden. Einige von der SAP AG und deren Vertriebspartnern vertriebene Softwareprodukte knnen Softwarekomponenten umfassen, die Eigentum anderer Softwarehersteller sind. SAP, R/3, xApps, xApp, SAP NetWeaver, Duet, SAP Business ByDesign, ByDesign, PartnerEdge und andere in diesem Dokument erwhnte SAP-Produkte und Services sowie die dazugehrigen Logos sind Marken oder eingetragene Marken der SAP AG in Deutschland und in mehreren anderen Lndern weltweit. Alle anderen in diesem Dokument erwhnten Namen von Produkten und Services sowie die damit verbundenen Firmenlogos sind Marken der jeweiligen Unternehmen. Die Angaben im Text sind unverbindlich und dienen lediglich zu Informationszwecken. Produkte knnen lnderspezifische Unterschiede aufweisen. Die in diesem Dokument enthaltenen Informationen sind Eigentum von SAP. Dieses Dokument ist eine Vorabversion und unterliegt nicht Ihrer Lizenzvereinbarung oder einer anderen Vereinbarung mit SAP. Dieses Dokument enthlt nur vorgesehene Strategien, Entwicklungen und Funktionen des SAP-Produkts und ist fr SAP nicht bindend, einen bestimmten Geschftsweg, eine Produktstrategie bzw. -entwicklung einzuschlagen. SAP bernimmt keine Verantwortung fr Fehler oder Auslassungen in diesen Materialien. SAP garantiert nicht die Richtigkeit oder Vollstndigkeit der Informationen, Texte, Grafiken, Links oder anderer in diesen Materialien enthaltenen Elemente. Diese Publikation wird ohne jegliche Gewhr, weder ausdrcklich noch stillschweigend, bereitgestellt. Dies gilt u. a., aber nicht ausschlielich, hinsichtlich der Gewhrleistung der Marktgngigkeit und der Eignung fr einen bestimmten Zweck sowie fr die Gewhrleistung der Nichtverletzung geltenden Rechts. SAP bernimmt keine Haftung fr Schden jeglicher Art, einschlielich und ohne Einschrnkung fr direkte, spezielle, indirekte oder Folgeschden im Zusammenhang mit der Verwendung dieser Unterlagen. Diese Einschrnkung gilt nicht bei Vorsatz oder grober Fahrlssigkeit.
Global IT
Die gesetzliche Haftung bei Personenschden oder die Produkthaftung bleibt unberhrt. Die Informationen, auf die Sie mglicherweise ber die in diesem Material enthaltenen Hotlinks zugreifen, unterliegen nicht dem Einfluss von SAP, und SAP untersttzt nicht die Nutzung von Internetseiten Dritter durch Sie und gibt keinerlei Gewhrleistungen oder Zusagen ber Internetseiten Dritter ab.
53